These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 25924878)

  • 1. Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension.
    Garcia V; Joseph G; Shkolnik B; Ding Y; Zhang FF; Gotlinger K; Falck JR; Dakarapu R; Capdevila JH; Bernstein KE; Schwartzman ML
    Am J Physiol Regul Integr Comp Physiol; 2015 Jul; 309(1):R71-8. PubMed ID: 25924878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent.
    Sodhi K; Wu CC; Cheng J; Gotlinger K; Inoue K; Goli M; Falck JR; Abraham NG; Schwartzman ML
    Hypertension; 2010 Nov; 56(5):871-8. PubMed ID: 20837888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction.
    Cheng J; Garcia V; Ding Y; Wu CC; Thakar K; Falck JR; Ramu E; Schwartzman ML
    Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1917-24. PubMed ID: 22723444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen-induced hypertension in angiotensinogen deficient mice: role of 20-HETE and EETS.
    Garcia V; Cheng J; Weidenhammer A; Ding Y; Wu CC; Zhang F; Gotlinger K; Falck JR; Schwartzman ML
    Prostaglandins Other Lipid Mediat; 2015; 116-117():124-30. PubMed ID: 25526688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension.
    Ding Y; Wu CC; Garcia V; Dimitrova I; Weidenhammer A; Joseph G; Zhang F; Manthati VL; Falck JR; Capdevila JH; Schwartzman ML
    Am J Physiol Renal Physiol; 2013 Sep; 305(5):F753-63. PubMed ID: 23825080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.
    Wu CC; Mei S; Cheng J; Ding Y; Weidenhammer A; Garcia V; Zhang F; Gotlinger K; Manthati VL; Falck JR; Capdevila JH; Schwartzman ML
    J Am Soc Nephrol; 2013 Jul; 24(8):1288-96. PubMed ID: 23641057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conflicting roles of 20-HETE in hypertension and renal end organ damage.
    Zhang C; Booz GW; Yu Q; He X; Wang S; Fan F
    Eur J Pharmacol; 2018 Aug; 833():190-200. PubMed ID: 29886242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (G
    Garcia V; Gilani A; Shkolnik B; Pandey V; Zhang FF; Dakarapu R; Gandham SK; Reddy NR; Graves JP; Gruzdev A; Zeldin DC; Capdevila JH; Falck JR; Schwartzman ML
    Circ Res; 2017 May; 120(11):1776-1788. PubMed ID: 28325781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
    Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice: NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTOR.
    Savas Ü; Wei S; Hsu MH; Falck JR; Guengerich FP; Capdevila JH; Johnson EF
    J Biol Chem; 2016 Aug; 291(32):16904-19. PubMed ID: 27298316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 20-HETE Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-κB Translocation and Promoter Binding.
    Garcia V; Shkolnik B; Milhau L; Falck JR; Schwartzman ML
    J Pharmacol Exp Ther; 2016 Mar; 356(3):525-33. PubMed ID: 26699146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NRF2 prevents hypertension, increased ADMA, microvascular oxidative stress, and dysfunction in mice with two weeks of ANG II infusion.
    Wang C; Luo Z; Carter G; Wellstein A; Jose PA; Tomlinson J; Leiper J; Welch WJ; Wilcox CS; Wang D
    Am J Physiol Regul Integr Comp Physiol; 2018 Mar; 314(3):R399-R406. PubMed ID: 29167164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension.
    Xia H; Sriramula S; Chhabra KH; Lazartigues E
    Circ Res; 2013 Oct; 113(9):1087-1096. PubMed ID: 24014829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 20-HETE and blood pressure regulation: clinical implications.
    Wu CC; Gupta T; Garcia V; Ding Y; Schwartzman ML
    Cardiol Rev; 2014; 22(1):1-12. PubMed ID: 23584425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive activity of Salvia elegans Vahl. (Lamiaceae): ACE inhibition and angiotensin II antagonism.
    Jiménez-Ferrer E; Badillo FH; González-Cortazar M; Tortoriello J; Herrera-Ruiz M
    J Ethnopharmacol; 2010 Jul; 130(2):340-6. PubMed ID: 20488233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local renin-angiotensin system mediates endothelial dilator dysfunction in aging arteries.
    Flavahan S; Chang F; Flavahan NA
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H849-54. PubMed ID: 27422988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease.
    Goto M; Hoxha N; Osman R; Dell KM
    Pediatr Nephrol; 2010 Dec; 25(12):2449-57. PubMed ID: 20798958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats.
    Sedláková L; Kikerlová S; Husková Z; Červenková L; Chábová VČ; Zicha J; Falck JR; Imig JD; Kompanowska-Jezierska E; Sadowski J; Krátký V; Červenka L; Kopkan L
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.